Catalyst Wire Dossier Catalyst Wire Dossier

DehydraTECH-GLP1 agonist

GLP-1 receptor agonist · Lexaria Bioscience Corp.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DehydraTECH-GLP1 agonist, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants [Phase 1]

See pricing